Since then, multiple studies have reported the co-localisation and concomitant overexpression of uPA and uPAR in patient tumour tissues (summarised in Table 1), which supports a role for uPAS in pancreatic cancer invasiveness. This evidence concerns the gene PLAU and neoplasm.